PharmaCyte Biotech
PMCB
PMCB
23 hedge funds and large institutions have $632K invested in PharmaCyte Biotech in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
23
Holders Change
-1
Holders Change %
-4.17%
% of All Funds
0.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
6
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
-$13.6K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$712 |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$78 |
| 4 |
JPMorgan Chase & Co
New York
|
-$20 |
| 5 |
BlackRock
New York
|
-$18 |
